WST West Pharmaceutical Services Market Capitalization to Book Value Ratio

Graphic logo of West Pharmaceutical Services Inc (WST)

West Pharmaceutical Services (WST) dominates the injectable packaging segment, where strict FDA regulations and demand for GLP-1 drugs create a unique ecosystem. The P/BV multiple history for the company on the GURU.Markets terminal linear chart contains the value 9.53, which indicates the level of this metric. The rock-solid pricing power of West Pharmaceutical Services (WST) is based on the difficulty of switching suppliers, which requires years of drug re-registration.

West Pharma Corp (WST) - Capitalization to Book Value Ratio from 07/04/2022 to 10/29/2026
Flagship merchandise of West Pharma

Fundamental asset selection is based on comparing the market value of a business with its actual net assets to determine the degree of a security's overvaluation. This indicator measures the premium to capital, reflecting market confidence in the stable profitability of West Pharmaceutical Services (WST) within the pharmaceutical packaging sector, which allows for the timely identification of correction risks through the ratio of the company's market valuation to its book value.

Direct competitors

Intuitive Surgical (ISRG) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio danaher.com|BDX (Becton Dickinson) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio STERIS PLC STE|Market Capitalization to Book Value Ratio BAX|Masimo Inc. - Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio STVN (Stevanato Group S.p.A.)|Market Capitalization to Book Value teleflex.com (TFX)|Merit Medical - Market Capitalization to Book Value Ratio|Envista Holdings Corporation (NVST) - Market Cap to Net Assets Ratio|ICUI: Market Capitalization to Book Value Ratio|Sirona Dental Systems (XRAY) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio LeMaitre Vascular, Inc.|Market Value to Book Value Ratio ATRC|Market Cap to Net Assets Ratio STAA (STAAR Surgical)|NAGE (Chromadex Corp) - Market Value to Book Value|Market Capitalization to Book Value Ratio ZIMV (ZimVie Dental)|Market Capitalization to Book Value AngioDynamics Inc. (ANGO)|CERS - Market Value to Book Value Ratio|TKNO (teknova.com) - Capitalization to Book Value Ratio|Monogram Orthopedics (MGRM) - Market Value to Book Value Ratio|STSS - Market Capitalization to Book Value|Market Cap to Net Assets Ratio INFU|UTMD (Utah Med) - Market Cap to Book Value Multiple|Market Value to Book Value Ratio KORU Medical Systems (KRMD)|NYXH (nyxoah.com) - Market Value to Book Value|Microbot Medical - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio Pro-Dex Inc PDEX|ZTEK - Market Value to Book Value Ratio|Elutia Corporation (ELUT) - Market Cap to Net Assets Ratio|MLSS: Market Capitalization to Book Value Ratio|Market-to-Book Ratio nexgel.com (NXGL)|Market Value to Book Value Ratio Retractable Technologies Inc.|Capitalization to Book Value Ratio HBIO (Harvard Bioscience Inc.)|Market Cap to Net Assets Ratio FEMY (Femasys Corp)|Market Cap to Book Value Multiple MHUA|Market Value to Book Value Ratio Predictive Oncology Inc. POAI|Market Capitalization to Book Value Callan JMB Inc. (CJMB)|ATRI: Market Cap to Net Assets Ratio|NeuroMetrix Inc (NURO) - Market Cap to Net Assets Ratio